AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 15 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,420,000 | -93.4% | 175,000 | -93.0% | 0.39% | -88.1% |
| Q3 2020 | $36,609,000 | +80.7% | 2,485,327 | +148.5% | 3.29% | +86.7% |
| Q4 2019 | $20,260,000 | +176.0% | 1,000,000 | 0.0% | 1.76% | +21.0% |
| Q1 2017 | $7,340,000 | +2.1% | 1,000,000 | -59.3% | 1.46% | -29.2% |
| Q2 2016 | $7,192,000 | +0.1% | 2,457,144 | 0.0% | 2.06% | -20.2% |
| Q1 2016 | $7,187,000 | +16.7% | 2,457,144 | 0.0% | 2.58% | -0.2% |
| Q4 2015 | $6,160,000 | -10.9% | 2,457,144 | 0.0% | 2.58% | -5.5% |
| Q3 2015 | $6,917,000 | +19.0% | 2,457,144 | +26.6% | 2.74% | +20.7% |
| Q2 2015 | $5,812,000 | -31.7% | 1,941,144 | 0.0% | 2.27% | -39.5% |
| Q1 2015 | $8,511,000 | -4.2% | 1,941,144 | -21.9% | 3.75% | -12.4% |
| Q4 2014 | $8,883,000 | +12.2% | 2,485,576 | +0.5% | 4.28% | +25.8% |
| Q3 2014 | $7,917,000 | – | 2,474,076 | – | 3.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |